聚焦直接口服抗凝剂：“旧”有及可能的新适应症以及改善临床管理的努力。 - Suppr

Suppr

超能文献

A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

作者信息

Prisco Domenico

机构信息

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Interdisciplinary Internal Medicine, Careggi University Hospital, Florence, Italy.

出版信息

Intern Emerg Med. 2018 Oct;13(7):985-988. doi: 10.1007/s11739-018-1954-3. Epub 2018 Sep 21.

DOI:10.1007/s11739-018-1954-3

PMID:30242604

Abstract

摘要

相似文献

A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Intern Emerg Med. 2018 Oct;13(7):985-988. doi: 10.1007/s11739-018-1954-3. Epub 2018 Sep 21.

The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.

J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):526-32. doi: 10.1177/1074248414525505. Epub 2014 Mar 21.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20.

Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.

Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.

Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.

Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.

Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants.

Expert Rev Cardiovasc Ther. 2015 Nov;13(11):1213-23. doi: 10.1586/14779072.2015.1096779. Epub 2015 Oct 15.

Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.

Ther Adv Cardiovasc Dis. 2018 Sep;12(9):247-262. doi: 10.1177/1753944718787384.

The new oral anticoagulants in atrial fibrillation: once daily or twice daily?

Vascul Pharmacol. 2013 Sep-Oct;59(3-4):53-62. doi: 10.1016/j.vph.2013.07.003. Epub 2013 Jul 18.

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.

Arch Cardiovasc Dis. 2018 Feb;111(2):85-94. doi: 10.1016/j.acvd.2017.04.008. Epub 2017 Oct 2.

Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).

Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28.

引用本文的文献

Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No.

Intern Emerg Med. 2020 Jan;15(1):5-7. doi: 10.1007/s11739-019-02224-y. Epub 2019 Nov 13.

Direct oral anticoagulants in factor VII deficiency patient.

Intern Emerg Med. 2019 Nov;14(8):1353-1356. doi: 10.1007/s11739-019-02186-1. Epub 2019 Sep 16.

本文引用的文献

Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients?

Intern Emerg Med. 2018 Oct;13(7):993-995. doi: 10.1007/s11739-018-1953-4. Epub 2018 Sep 27.

A clinical conundrum: to measure or not measure direct oral anticoagulants before a surgery or procedure?

Intern Emerg Med. 2018 Oct;13(7):997-999. doi: 10.1007/s11739-018-1930-y. Epub 2018 Aug 24.

The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey.

Intern Emerg Med. 2018 Oct;13(7):1005-1007. doi: 10.1007/s11739-018-1929-4. Epub 2018 Aug 16.

NOAC in "real world" patients with atrial fibrillation in Italy: results from the ISPAF-2 (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.

Intern Emerg Med. 2018 Oct;13(7):1069-1075. doi: 10.1007/s11739-018-1896-9. Epub 2018 Jun 28.

Edoxaban for the treatment of cancer associated venous thromboembolism as an alternative to low-molecular-weight-heparin.

Intern Emerg Med. 2018 Oct;13(7):1089-1091. doi: 10.1007/s11739-018-1886-y. Epub 2018 Jun 12.

Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Intern Emerg Med. 2018 Oct;13(7):1001-1004. doi: 10.1007/s11739-018-1883-1. Epub 2018 May 24.

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry.

Intern Emerg Med. 2018 Oct;13(7):1051-1058. doi: 10.1007/s11739-018-1877-z. Epub 2018 May 22.

Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort.

Intern Emerg Med. 2018 Oct;13(7):1059-1067. doi: 10.1007/s11739-018-1857-3. Epub 2018 May 7.

Drug plasma level measurement in management of severe bleeding during direct oral anticoagulant treatment: case report and perspective.

Intern Emerg Med. 2018 Oct;13(7):1093-1096. doi: 10.1007/s11739-018-1858-2. Epub 2018 May 3.

The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures.

Intern Emerg Med. 2018 Oct;13(7):1029-1036. doi: 10.1007/s11739-018-1854-6. Epub 2018 Apr 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验